ROBB GARY CHARLES (Chief Business Officer) received a stock award from CORCEPT THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 3/4/2026ACC: 0001193125-26-092158
Officer· Chief Business Officer
Since Mar 2026
+877.00
Net shares
Net buyer
$4.4K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
998.00 acquired · 121.00 disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+499.00
Price / share
$35.97
Trade value
$17.95K
% of position
0.6%
3/2/2026
78.63K→79.13K
Common Stock
Direct
Shares
+499.00
Price / share
—
Trade value
—
% of position
0.6%
3/2/2026
79.13K→79.62K
Common Stock
Direct
Shares
−121.00
Price / share
$35.97
Trade value
$4.35K
% of position
0.2%
3/3/2026
79.62K→79.50K
Total
Net shares
+877.00
Net value
$13.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | A · Award | +499.00 | $35.97 | $17.95K | 0.6% | 78.63K | 79.13K |
| Common Stock Direct | 3/2/2026 | A · Award | +499.00 | — | — | 0.6% | 79.13K | 79.62K |
| Common Stock Direct | 3/3/2026 | F · Tax Withholding | −121.00 | $35.97 | $4.35K | 0.2% | 79.62K | 79.50K |
| Total | +877.00 | $13.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned11.57K
Common Stock
IndirectShares owned11.57K
Total
23.14K indirect23.14K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 11.57K | Indirect |
| Common Stock | 11.57K | Indirect |
| Total | 23.14K | 23.14K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported